The global artificial tears market is expected to register a valuation of USD 3.4 billion in 2024 and further expand at a CAGR of 5.4% to reach a valuation of USD 5.8 billion by 2034. According to Future Market Insights, glycerine tears are leading the market with a share of about 26.7% in 2024 within the global artificial tears market size.
| Data Points | Market Insights |
|---|---|
| Artificial Tears Market Value 2023 | USD 3.3 billion |
| Artificial Tears Market Value 2024 | USD 3.4 billion |
| Artificial Tears Market Value 2034 | USD 5.8 billion |
| Artificial Tears Market CAGR | 5.4% |
Artificial tears eye drops keep the outer layer of the eyes wet. The market for artificial tears has experienced substantial growth due to the increasing need for greasing eye products in ophthalmic therapy. An increasing percentage of people suffer from dry eye syndrome, which might open up lucrative new markets for artificial tears.
Artificial tears are used to moisten contact lenses, examinations, and routine eye check-ups. The market is expanding due to the rise in eye and post-eye surgeries
The artificial tears market is exponentially growing due to government initiatives and awareness of dry eye syndrome. Rising rates of dry eye disease and the geriatric population fuel the market's expansion
The National Programme for Control of Blindness (NPCB) and other government programs are increasing public awareness through pharmaceuticals and distribution networks. Furthermore, the need for eye care products and the availability of eye drops to treat eye disease is likely to boost the artificial tears market online.
Artificial tear brands in the global market for artificial tears are competing for market share by acquiring local and small manufacturing. Manufacturers are implementing advertising and social media initiatives to increase the company's sales and market share to promote their products in the marketplace.
Product safety concerns that result in restricting the use of artificial tears products. Additionally, some safety issues with teardrops include the risk of contamination and unfavorable reactions to the preservatives used in the product. The usage is restricted due to safety concerns, and the various eye-related conditions may lead to reduced productivity, negatively influencing the quality of life.
The adverse effects such as eye irritation, eye pain, blurred vision, red eyes, and foreign body sensation in the eyes are undoubtedly challenging the market's expansion. Furthermore, the need for artificial tears is being constrained by developing several drugs that can reduce the irritation caused by dry eye syndrome. Certain restrictions are anticipated to lead to reduced demand for artificial tears, which would, in turn, limit artificial tears market expansion.
The sale of artificial tears expanded at a CAGR of 5.0% from 2019 to 2023, owing to the rising dry eye syndrome and increasing pollution rate.
Artificial tears are lubricant eye drops used to reduce the dryness and irritation caused by keratoconjunctivitis sicca. These products, also known as ocular lubricants, are built explicitly to irritate and relieve burning and discomfort caused by dry eyes. Long-term computer use, fatigue, dry and smoky weather, and other reasons can all contribute to dry eyes.
The Dry Eye Directory represents statistics; currently, dry eyes affect between 16 and 49 million Americans. It means 5 to 15% of the total population, and according to a Gallup Poll, 29 million Americans are likely to suffer from dry eye disease by 2034.
The sales of artificial tears in the market are expected to rise during the forecast period due to excessive eye drops and lubrication demand. With the abovementioned factors, the global market is expected to grow 5.4% during the forecast period.
| Country/region | CAGR (2024 to 2034) |
|---|---|
| United States | 6.7% |
| China | 10.2% |
| India | 4.7% |
The United States is estimated to hold a CAGR of 6.7% of the global market through 2034. The United States artificial tears market currently sees several pharmaceutical manufacturers collaborating with eye care solution providers to deliver high-quality products for commercial use.
To increase the impact of manufacturing position on the global market, the industry's players are concentrating on promoting their brands and consolidating supply chain distribution networks in the United States.
India is set to exhibit a growth rate of nearly 4.7% ;in the artificial tears market through 2034. In India, cases of dry eye syndrome are increasing rapidly. For instance, in July 2020, a report published by the Indian Journal of Ophthalmology, a study from north India estimated that dry eye disease (DED) is 32% in north India, and 81% of cases were classified as severe DED based on symptoms.
Growing Prevalence of Eye Disorders Upsurge China Artificial Tears Market
China is likely to secure a 10.2% CAGR in the global artificial tears market by 2034, owing to the prevalence of dryness in the eyes and ocular surface irritation
One of the world's rapidly growing aging populations is in China. For instance, records stated by the World Health Organization (WHO), By 2040, it is anticipated that 28% of China's population will be over 60. A significant increase in the country's senior population has led to China experiencing substantial growth in the market.
Glycerine tears are expected to present a growth of 4.5% by the end of the forecast period, with a market share value of 26.4% by the end of 2024. Glycerine tears help to decrease symptoms of dry eyes, keep the eye moist, and help to protect the eye from injury.
| Product Type | Glycerine |
|---|---|
| CAGR (2024 to 2034) | 4.5% |
Solutions hold an artificial tears market share of 29.2% in 2024 and are expected to grow gradually over the forecast period, with an estimated CAGR of ;5.0%. Generally, artificial tear solutions help maintain moisture and lubricate dry eyes on the outer surfaces of the eyes. These eye drops can be used to treat aging-related dry eyes.
| Dosage Form | Solution |
|---|---|
| CAGR (2024 to 2034) | 5.0% |
Non-preservative-based formulation holds a prominent market share value of 55.2% in 2024, a CAGR of 5.6% by the end of the forecast period. Non-preservative eye drops do not contain any preservatives to stop the growth of bacteria. Non-preservative eye drops are available for three days (inpatients) or seven days (outpatients) in various application containers.
| Formulation | Non-preservative-based Formulation |
|---|---|
| CAGR (2024 to 2034) | 5.6% |
Dry eye syndrome holds a market share of 34.2% in 2024 and is expected to display gradual growth over the forecast period, with an estimated CAGR of 5.4% in 2034. Dry eye syndrome is caused due to autoimmune disease, hormone changes, allergic eye disease, or inflamed eyelid glands. Increased tear evaporation or decreased tear production caused by dry eyes syndrome holds a prominent position in the indication segment of the artificial tear market.
| Indication | Dry Eye Syndrome |
|---|---|
| CAGR (2024 to 2034) | 5.4% |
Retail pharmacies hold a prominent market share value of 38.0% in 2024, with a CAGR of 4.6% through 2034. Retail pharmacy stores have various products of different brands and can be easily located near residential areas, hence gaining a prominent position in the artificial tears market.
| Distribution Channel | Retail Pharmacies |
|---|---|
| CAGR (2024 to 2034) | 4.6% |
The market for producing artificial tears is fragmented, with several competitors. These businesses employ collaborations, partnerships, mergers and acquisitions, and new product releases to satisfy consumer demand and increase their client base. Various key players are launching types of artificial tears eye drops to upsurge the global artificial tears market size.
Recent Developments in the Artificial Tears Market
| Attribute | Details |
|---|---|
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | USD billion for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania and Middle East & Africa |
| Key Countries Covered | The United States, Canada, Brazil, Mexico, Argentina, The United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, South Africa and North Africa |
| Key Market Segments Covered | Ingredients, Dosage Form, Route of Administration, Indication, Distribution Channel, and Region |
| Key Companies Profiled | AbbVie, Inc.; Akorn, Inc.; Alcon; Bausch & Lomb; Johnson & Johnson; Eyevance Pharmaceuticals LLC; Ocusoft; I- MED PHARMA; Santen Pharmaceutical Co. Ltd; Similasan Corporation; Sun Pharmaceutical Industries Ltd; Ursapharm Arzneimittel GmbH; Novartis International AG; AFT Pharmaceuticals; Allergan plc; Rohto Pharmaceutical Co., Ltd; VISUfarma; Otsuka Pharmaceutical Co., Ltd.; NovaMedica LLC; ENTOD Research Cell UK Ltd; OASIS Medical, Inc; Abbott Medical Optics Inc |
| Pricing | Available upon Request |
Table 01: Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Product
Table 02: Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
Table 03: Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Formulation
Table 04: Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
Table 05: Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 06: Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
Table 07: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 08: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Product
Table 09: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
Table 10: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Formulation
Table 11: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
Table 12: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 13: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 14: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Product
Table 15: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
Table 16: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Formulation
Table 17: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
Table 18: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 19: Europe Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 20: Europe Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Product
Table 21: Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
Table 22: Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Formulation
Table 23: Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
Table 24: Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 25: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 26: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Product
Table 27: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
Table 28: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Formulation
Table 29: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
Table 30: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 31: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 32: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Product
Table 33: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
Table 34: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Formulation
Table 35: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
Table 36: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 37: Oceania Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 38: Oceania Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Product
Table 39: Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
Table 40: Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Formulation
Table 41: Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
Table 42: Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 43: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 44: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Product
Table 45: Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
Table 46: Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Formulation
Table 47: Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
Table 48: Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Figure 01: Global Market Value (US$ Million) Analysis, 2017 to 2022
Figure 02: Global Market Forecast & Y-o-Y Growth, 2023 to 2033
Figure 03: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2022–2033
Figure 04: Global Market Value Share (%) Analysis 2023 and 2033, by Product
Figure 05: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Product
Figure 06: Global Market Attractiveness Analysis 2023 to 2033, by Product
Figure 07: Global Market Value Share (%) Analysis 2023 and 2033, by Dosage Form
Figure 08: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Dosage Form
Figure 09: Global Market Attractiveness Analysis 2023 to 2033, by Dosage Form
Figure 10: Global Market Value Share (%) Analysis 2023 and 2033, by Formulation
Figure 11: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Formulation
Figure 12: Global Market Attractiveness Analysis 2023 to 2033, by Formulation
Figure 13: Global Market Value Share (%) Analysis 2023 and 2033, by Indication
Figure 14: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Indication
Figure 15: Global Market Attractiveness Analysis 2023 to 2033, by Indication
Figure 16: Global Market Value Share (%) Analysis 2023 and 2033, by Distribution Channel
Figure 17: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Distribution Channel
Figure 18: Global Market Attractiveness Analysis 2023 to 2033, by Distribution Channel
Figure 19: Global Market Value Share (%) Analysis 2023 and 2033, by Region
Figure 20: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Region
Figure 21: Global Market Attractiveness Analysis 2023 to 2033, by Region
Figure 22: North America Market Value (US$ Million) Analysis, 2017 to 2022
Figure 23: North America Market Value (US$ Million) Forecast, 2023-2033
Figure 24: North America Market Value Share, by Product (2023 E)
Figure 25: North America Market Value Share, by Dosage Form (2023 E)
Figure 26: North America Market Value Share, by Formulation (2023 E)
Figure 27: North America Market Value Share, by Indication (2023 E)
Figure 28: North America Market Value Share, by Distribution Channel (2023 E)
Figure 29: North America Market Value Share, by Country (2023 E)
Figure 30: North America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 31: North America Market Attractiveness Analysis by Dosage Form, 2023 to 2033
Figure 32: North America Market Attractiveness Analysis by Formulation, 2023 to 2033
Figure 33: North America Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 34: North America Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 35: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 36: USA. Market Value Proportion Analysis, 2022
Figure 37: Global Vs. USA. Growth Comparison
Figure 38: USA. Market Share Analysis (%) by Product, 2022 to 2033
Figure 39: USA. Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 40: USA. Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 41: USA. Market Share Analysis (%) by Indication, 2022 to 2033
Figure 42: USA. Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 43: Canada Market Value Proportion Analysis, 2022
Figure 44: Global Vs. Canada. Growth Comparison
Figure 45: Canada Market Share Analysis (%) by Product, 2022 to 2033
Figure 46: Canada Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 47: Canada Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 48: Canada Market Share Analysis (%) by Indication, 2022 to 2033
Figure 49: Canada Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 50: Latin America Market Value (US$ Million) Analysis, 2017 to 2022
Figure 51: Latin America Market Value (US$ Million) Forecast, 2023-2033
Figure 52: Latin America Market Value Share, by Product (2023 E)
Figure 53: Latin America Market Value Share, by Dosage Form (2023 E)
Figure 54: Latin America Market Value Share, by Formulation (2023 E)
Figure 55: Latin America Market Value Share, by Indication (2023 E)
Figure 56: Latin America Market Value Share, by Distribution Channel (2023 E)
Figure 57: Latin America Market Value Share, by Country (2023 E)
Figure 58: Latin America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 59: Latin America Market Attractiveness Analysis by Dosage Form, 2023 to 2033
Figure 60: Latin America Market Attractiveness Analysis by Formulation, 2023 to 2033
Figure 61: Latin America Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 62: Latin America Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 63: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 64: Mexico Market Value Proportion Analysis, 2022
Figure 65: Global Vs Mexico Growth Comparison
Figure 66: Mexico Market Share Analysis (%) by Product, 2022 to 2033
Figure 67: Mexico Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 68: Mexico Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 69: Mexico Market Share Analysis (%) by Indication, 2022 to 2033
Figure 70: Mexico Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 71: Brazil Market Value Proportion Analysis, 2022
Figure 72: Global Vs. Brazil. Growth Comparison
Figure 73: Brazil Market Share Analysis (%) by Product, 2022 to 2033
Figure 74: Brazil Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 75: Brazil Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 76: Brazil Market Share Analysis (%) by Indication, 2022 to 2033
Figure 77: Brazil Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 78: Argentina Market Value Proportion Analysis, 2022
Figure 79: Global Vs Argentina Growth Comparison
Figure 80: Argentina Market Share Analysis (%) by Product, 2022 to 2033
Figure 81: Argentina Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 82: Argentina Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 83: Argentina Market Share Analysis (%) by Indication, 2022 to 2033
Figure 84: Argentina Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 85: Europe Market Value (US$ Million) Analysis, 2017 to 2022
Figure 86: Europe Market Value (US$ Million) Forecast, 2023-2033
Figure 87: Europe Market Value Share, by Product (2023 E)
Figure 88: Europe Market Value Share, by Dosage Form (2023 E)
Figure 89: Europe Market Value Share, by Formulation (2023 E)
Figure 90: Europe Market Value Share, by Indication (2023 E)
Figure 91: Europe Market Value Share, by Distribution Channel (2023 E)
Figure 92: Europe Market Value Share, by Country (2023 E)
Figure 93: Europe Market Attractiveness Analysis by Product, 2023 to 2033
Figure 94: Europe Market Attractiveness Analysis by Dosage Form, 2023 to 2033
Figure 95: Europe Market Attractiveness Analysis by Formulation, 2023 to 2033
Figure 96: Europe Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 97: Europe Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 98: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 99: UK Market Value Proportion Analysis, 2022
Figure 100: Global Vs. UK Growth Comparison
Figure 101: UK Market Share Analysis (%) by Product, 2022 to 2033
Figure 102: UK Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 103: UK Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 104: UK Market Share Analysis (%) by Indication, 2022 to 2033
Figure 105: UK Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 106: Germany Market Value Proportion Analysis, 2022
Figure 107: Global Vs. Germany Growth Comparison
Figure 108: Germany Market Share Analysis (%) by Product, 2022 to 2033
Figure 109: Germany Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 110: Germany Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 111: Germany Market Share Analysis (%) by Indication, 2022 to 2033
Figure 112: Germany Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 113: Italy Market Value Proportion Analysis, 2022
Figure 114: Global Vs. Italy Growth Comparison
Figure 115: Italy Market Share Analysis (%) by Product, 2022 to 2033
Figure 116: Italy Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 117: Italy Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 118: Italy Market Share Analysis (%) by Indication, 2022 to 2033
Figure 119: Italy Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 120: France Market Value Proportion Analysis, 2022
Figure 121: Global Vs France Growth Comparison
Figure 122: France Market Share Analysis (%) by Product, 2022 to 2033
Figure 123: France Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 124: France Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 125: France Market Share Analysis (%) by Indication, 2022 to 2033
Figure 126: France Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 127: Spain Market Value Proportion Analysis, 2022
Figure 128: Global Vs Spain Growth Comparison
Figure 129: Spain Market Share Analysis (%) by Product, 2022 to 2033
Figure 130: Spain Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 131: Spain Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 132: Spain Market Share Analysis (%) by Indication, 2022 to 2033
Figure 133: Spain Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 134: Russia Market Value Proportion Analysis, 2022
Figure 135: Global Vs Russia Growth Comparison
Figure 136: Russia Market Share Analysis (%) by Product, 2022 to 2033
Figure 137: Russia Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 138: Russia Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 139: Russia Market Share Analysis (%) by Indication, 2022 to 2033
Figure 140: Russia Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 141: BENELUX Market Value Proportion Analysis, 2022
Figure 142: Global Vs BENELUX Growth Comparison
Figure 143: BENELUX Market Share Analysis (%) by Product, 2022 to 2033
Figure 144: BENELUX Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 145: BENELUX Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 146: BENELUX Market Share Analysis (%) by Indication, 2022 to 2033
Figure 147: BENELUX Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 148: East Asia Market Value (US$ Million) Analysis, 2017 to 2022
Figure 149: East Asia Market Value (US$ Million) Forecast, 2023-2033
Figure 150: East Asia Market Value Share, by Product (2023 E)
Figure 151: East Asia Market Value Share, by Dosage Form (2023 E)
Figure 152: East Asia Market Value Share, by Formulation (2023 E)
Figure 153: East Asia Market Value Share, by Indication (2023 E)
Figure 154: East Asia Market Value Share, by Distribution Channel (2023 E)
Figure 155: East Asia Market Value Share, by Country (2023 E)
Figure 156: East Asia Market Attractiveness Analysis by Product, 2023 to 2033
Figure 157: East Asia Market Attractiveness Analysis by Dosage Form, 2023 to 2033
Figure 158: East Asia Market Attractiveness Analysis by Formulation, 2023 to 2033
Figure 159: East Asia Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 160: East Asia Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 161: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 162: China Market Value Proportion Analysis, 2022
Figure 163: Global Vs. China Growth Comparison
Figure 164: China Market Share Analysis (%) by Product, 2022 to 2033
Figure 165: China Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 166: China Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 167: China Market Share Analysis (%) by Indication, 2022 to 2033
Figure 168: China Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 169: Japan Market Value Proportion Analysis, 2022
Figure 170: Global Vs. Japan Growth Comparison
Figure 171: Japan Market Share Analysis (%) by Product, 2022 to 2033
Figure 172: Japan Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 173: Japan Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 174: Japan Market Share Analysis (%) by Indication, 2022 to 2033
Figure 175: Japan Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 176: South Korea Market Value Proportion Analysis, 2022
Figure 177: Global Vs South Korea Growth Comparison
Figure 178: South Korea Market Share Analysis (%) by Product, 2022 to 2033
Figure 179: South Korea Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 180: South Korea Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 181: South Korea Market Share Analysis (%) by Indication, 2022 to 2033
Figure 182: South Korea Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 183: South Asia Market Value (US$ Million) Analysis, 2017 to 2022
Figure 184: South Asia Market Value (US$ Million) Forecast, 2023-2033
Figure 185: South Asia Market Value Share, by Product (2023 E)
Figure 186: South Asia Market Value Share, by Dosage Form (2023 E)
Figure 187: South Asia Market Value Share, by Formulation (2023 E)
Figure 188: South Asia Market Value Share, by Indication (2023 E)
Figure 189: South Asia Market Value Share, by Distribution Channel (2023 E)
Figure 190: South Asia Market Value Share, by Country (2023 E)
Figure 191: South Asia Market Attractiveness Analysis by Product, 2023 to 2033
Figure 192: South Asia Market Attractiveness Analysis by Dosage Form, 2023 to 2033
Figure 193: South Asia Market Attractiveness Analysis by Formulation, 2023 to 2033
Figure 194: South Asia Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 195: South Asia Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 196: South Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 197: India Market Value Proportion Analysis, 2022
Figure 198: Global Vs. India Growth Comparison
Figure 199: India Market Share Analysis (%) by Product, 2022 to 2033
Figure 200: India Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 201: India Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 202: India Market Share Analysis (%) by Indication, 2022 to 2033
Figure 203: India Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 204: Indonesia Market Value Proportion Analysis, 2022
Figure 205: Global Vs. Indonesia Growth Comparison
Figure 206: Indonesia Market Share Analysis (%) by Product, 2022 to 2033
Figure 207: Indonesia Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 208: Indonesia Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 209: Indonesia Market Share Analysis (%) by Indication, 2022 to 2033
Figure 210: Indonesia Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 211: Malaysia Market Value Proportion Analysis, 2022
Figure 212: Global Vs. Malaysia Growth Comparison
Figure 213: Malaysia Market Share Analysis (%) by Product, 2022 to 2033
Figure 214: Malaysia Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 215: Malaysia Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 216: Malaysia Market Share Analysis (%) by Indication, 2022 to 2033
Figure 217: Malaysia Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 218: Thailand Market Value Proportion Analysis, 2022
Figure 219: Global Vs. Thailand Growth Comparison
Figure 220: Thailand Market Share Analysis (%) by Product, 2022 to 2033
Figure 221: Thailand Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 222: Thailand Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 223: Thailand Market Share Analysis (%) by Indication, 2022 to 2033
Figure 224: Thailand Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 225: Oceania Market Value (US$ Million) Analysis, 2017 to 2022
Figure 226: Oceania Market Value (US$ Million) Forecast, 2023-2033
Figure 227: Oceania Market Value Share, by Product (2023 E)
Figure 228: Oceania Market Value Share, by Dosage Form (2023 E)
Figure 229: Oceania Market Value Share, by Formulation (2023 E)
Figure 230: Oceania Market Value Share, by Indication (2023 E)
Figure 231: Oceania Market Value Share, by Distribution Channel (2023 E)
Figure 232: Oceania Market Value Share, by Country (2023 E)
Figure 233: Oceania Market Attractiveness Analysis by Product, 2023 to 2033
Figure 234: Oceania Market Attractiveness Analysis by Dosage Form, 2023 to 2033
Figure 235: Oceania Market Attractiveness Analysis by Formulation, 2023 to 2033
Figure 236: Oceania Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 237: Oceania Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 238: Oceania Market Attractiveness Analysis by Country, 2023 to 2033
Figure 239: Australia Market Value Proportion Analysis, 2022
Figure 240: Global Vs. Australia Growth Comparison
Figure 241: Australia Market Share Analysis (%) by Product, 2022 to 2033
Figure 242: Australia Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 243: Australia Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 244: Australia Market Share Analysis (%) by Indication, 2022 to 2033
Figure 245: Australia Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 246: New Zealand Market Value Proportion Analysis, 2022
Figure 247: Global Vs New Zealand Growth Comparison
Figure 248: New Zealand Market Share Analysis (%) by Product, 2022 to 2033
Figure 249: New Zealand Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 250: New Zealand Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 251: New Zealand Market Share Analysis (%) by Indication, 2022 to 2033
Figure 252: New Zealand Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 253: Middle East & Africa Market Value (US$ Million) Analysis, 2017 to 2022
Figure 254: Middle East & Africa Market Value (US$ Million) Forecast, 2023-2033
Figure 255: Middle East & Africa Market Value Share, by Product (2023 E)
Figure 256: Middle East & Africa Market Value Share, by Dosage Form (2023 E)
Figure 257: Middle East & Africa Market Value Share, by Formulation (2023 E)
Figure 258: Middle East & Africa Market Value Share, by Indication (2023 E)
Figure 259: Middle East & Africa Market Value Share, by Distribution Channel (2023 E)
Figure 260: Middle East & Africa Market Value Share, by Country (2023 E)
Figure 261: Middle East & Africa Market Attractiveness Analysis by Product, 2023 to 2033
Figure 262: Middle East & Africa Market Attractiveness Analysis by Dosage Form, 2023 to 2033
Figure 263: Middle East & Africa Market Attractiveness Analysis by Formulation, 2023 to 2033
Figure 264: Middle East & Africa Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 265: Middle East & Africa Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 266: Middle East & Africa Market Attractiveness Analysis by Country, 2023 to 2033
Figure 267: GCC Countries Market Value Proportion Analysis, 2022
Figure 268: Global Vs GCC Countries Growth Comparison
Figure 269: GCC Countries Market Share Analysis (%) by Product, 2022 to 2033
Figure 270: GCC Countries Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 271: GCC Countries Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 272: GCC Countries Market Share Analysis (%) by Indication, 2022 to 2033
Figure 273: GCC Countries Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 274: Türkiye Market Value Proportion Analysis, 2022
Figure 275: Global Vs. Türkiye Growth Comparison
Figure 276: Türkiye Market Share Analysis (%) by Product, 2022 to 2033
Figure 277: Türkiye Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 278: Türkiye Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 279: Türkiye Market Share Analysis (%) by Indication, 2022 to 2033
Figure 280: Türkiye Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 281: South Africa Market Value Proportion Analysis, 2022
Figure 282: Global Vs. South Africa Growth Comparison
Figure 283: South Africa Market Share Analysis (%) by Product, 2022 to 2033
Figure 284: South Africa Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 285: South Africa Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 286: South Africa Market Share Analysis (%) by Indication, 2022 to 2033
Figure 287: South Africa Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 288: North Africa Market Value Proportion Analysis, 2022
Figure 289: Global Vs North Africa Growth Comparison
Figure 290: North Africa Market Share Analysis (%) by Product, 2022 to 2033
Figure 291: North Africa Market Share Analysis (%) by Dosage Form, 2022 to 2033
Figure 292: North Africa Market Share Analysis (%) by Formulation, 2022 to 2033
Figure 293: North Africa Market Share Analysis (%) by Indication, 2022 to 2033
Figure 294: North Africa Market Share Analysis (%) by Distribution Channel, 2022 to 2033
The global artificial tears market is worth USD 3.4 billion in 2024 and is set to expand 1.7X over the next ten years.
Rising awareness about dry eye syndrome and adoption rate of artificial tears.
The United States, China, and the United Kingdom are expected to drive demand for the artificial tears market.
The artificial tears market is expected to reach a sales revenue to register a 5.4% CAGR.
The United States, India, and China are the key producers of artificial tears.
The United States accounted for a CAGR of 6.7% in the artificial tears market through 2034.
From 2019 to 2023, the market for artificial tears expanded by 5.0%.
India accounts for a CAGR of 4.7% in the global market during the forecast period.
Explore Similar Insights
Artificial Tears Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
